Detailed financial statements for Kenvue Inc. (KVUE): income statement, balance sheet and cash-flow summary. Track margins, debt, liquidity and profitability trends year over year: ten fiscal years free and up to 20 with Premium.
Kenvue Inc. functions as a global leader in the consumer health sector. The company structures its operations across three primary divisions: Self Care, Skin Health and Beauty, and Essential Health. Within the Self Care unit, it offers a diverse range of products for common conditions like coughs, colds, and allergies, in addition to pain relief, digestive health, and smoking cessation aids, featuring prominent brands such as Tylenol, Nicorette, and Zyrtec.
Analysis Summary
Kenvue Inc. reported revenue of $15.12B in the most recent fiscal year, growing at a 5-year CAGR of 0.9%.
Trailing-twelve-month margins: gross margin 58.2%, operating margin 19.5%, net margin 10.8%. Free cash flow grew at -11.5% CAGR over 5 years.
At the current price of $17.39, KVUE trades at a P/E of 19.77 and an ROE of 13.66%. Market capitalisation stands at $33.4B, placing it among large-cap names.
Balance sheet quality for KVUE: current ratio of 1.0, net debt of $7.46B. A debt-to-equity below 1.0 typically signals conservative capital structure, while a current ratio above 1.5 indicates comfortable short-term liquidity.
Cash flow quality is strong: free cash flow of $1.72B represents 117% conversion of reported net income. High conversion (above 90%) suggests earnings translate cleanly into cash; lower conversion may indicate working capital tightness or accounting timing differences.
Income Statement (10y)
| Year | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Revenue | $14.32B | $14.47B | $15.05B | $14.95B | $15.44B | $15.46B | $15.12B |
| Cost of Revenue | $6.66B | $6.62B | $6.63B | $6.67B | $6.80B | $6.50B | $6.33B |
| Gross Profit | $7.66B | $7.85B | $8.42B | $8.29B | $8.64B | $8.96B | $8.79B |
| Research & Development | 0 | 0 | 0 | 0 | 0 | 0 | $382.0M |
| Selling, General & Admin | $5.20B | $4.96B | $5.48B | $5.63B | $6.14B | $6.03B | $6.09B |
| Operating Expenses | $5.82B | $8.83B | $5.50B | $5.61B | $6.13B | $7.12B | $6.09B |
| Operating Income | $1.85B | -$979.0M | $2.92B | $2.67B | $2.51B | $1.84B | $2.70B |
| EBITDA | $3.11B | $3.73B | $3.66B | $3.28B | $3.17B | $2.47B | $2.94B |
| Interest Expense | 0 | 0 | 0 | 0 | $358.0M | $431.0M | $379.0M |
| Pre-tax Income | $2.12B | -$1.02B | $2.92B | $2.64B | $2.19B | $1.42B | $2.00B |
| Income Tax | $685.0M | -$137.0M | $847.0M | $573.0M | $526.0M | $385.0M | $529.0M |
| Net Income | $1.44B | -$879.0M | $2.08B | $2.06B | $1.66B | $1.03B | $1.47B |
| EPS | $0.76 | $-0.47 | $1.10 | $1.08 | $0.90 | $0.54 | $0.77 |
| EPS (Diluted) | $0.76 | $-0.47 | $1.10 | $1.08 | $0.87 | $0.54 | $0.76 |
| Shares Outstanding (Diluted) | $1.89B | $1.89B | $1.89B | $1.91B | $1.92B | $1.92B | $1.92B |
Income Statement (Quarterly)
| Year | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|---|---|---|---|
| Revenue | $3.76B | $3.78B | $3.91B | $3.96B |
| Gross Profit | $2.23B | $2.14B | $2.30B | $2.30B |
| Operating Income | $629.0M | $825.0M | $855.0M | $699.0M |
| EBITDA | $760.0M | $663.0M | $910.0M | $833.0M |
| Net Income | $398.0M | $330.0M | $474.0M | $456.0M |
| EPS | $0.21 | $0.17 | $0.25 | $0.24 |
| EPS (Diluted) | $0.21 | $0.17 | $0.25 | $0.24 |
Balance Sheet (10y)
| Year | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $618.0M | $740.0M | $1.23B | $1.38B | $1.07B | $1.06B |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | $2.13B | $2.33B | $2.30B | $2.64B | $2.66B | $2.81B |
| Inventory | $1.69B | $1.70B | $2.23B | $1.85B | $1.59B | $1.67B |
| Total Current Assets | $4.59B | $4.93B | $5.88B | $6.14B | $5.53B | $5.70B |
| Property, Plant & Equipment | $1.96B | $1.83B | $1.82B | $2.04B | $1.85B | $2.21B |
| Goodwill | $10.33B | $9.81B | $9.19B | $9.27B | $8.84B | $9.51B |
| Intangible Assets | $11.61B | $10.70B | $9.85B | $9.62B | $8.47B | $8.69B |
| Total Assets | $29.18B | $27.93B | $27.32B | $27.85B | $25.60B | $27.08B |
| Accounts Payable | $1.58B | $1.83B | $1.83B | $2.49B | $2.25B | $2.47B |
| Short-term Debt | 0 | 0 | 0 | $599.0M | $1.55B | $1.45B |
| Total Current Liabilities | $7.49B | $4.04B | $3.93B | $5.48B | $5.74B | $5.95B |
| Long-term Debt | 0 | 0 | $8.93B | $7.69B | $6.94B | $7.07B |
| Total Liabilities | $10.82B | $7.53B | $7.35B | $16.64B | $15.93B | $16.31B |
| Retained Earnings | 0 | 0 | 0 | $429.0M | -$93.0M | -$204.0M |
| Total Equity | $18.36B | $20.40B | $19.97B | $11.21B | $9.67B | $10.77B |
| Total Debt | 0 | $129.0M | $9.05B | $8.43B | $8.72B | $8.52B |
| Net Debt | -$618.0M | -$611.0M | $7.82B | $7.04B | $7.65B | $7.46B |
| Working Capital | -$2.90B | $885.0M | $1.95B | $657.0M | -$214.0M | -$248.0M |
Balance Sheet (Quarterly)
| Year | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|---|---|---|---|
| Cash & Equivalents | $1.14B | $1.06B | $1.07B | $1.11B |
| Total Assets | $27.25B | $27.08B | $26.85B | $26.73B |
| Total Liabilities | $16.61B | $16.31B | $16.25B | $16.18B |
| Total Equity | $10.63B | $10.77B | $10.61B | $10.55B |
| Total Debt | $9.11B | $8.52B | $8.66B | $8.48B |
Cash Flow (10y)
| Year | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Net Income | $1.44B | -$879.0M | $2.03B | $2.09B | $1.66B | $1.03B | $1.47B |
| Depreciation & Amortization | $709.0M | $746.0M | $731.0M | $644.0M | $627.0M | $622.0M | $557.0M |
| Stock-based Compensation | $102.0M | $115.0M | $141.0M | $137.0M | $188.0M | $254.0M | $136.0M |
| Change in Working Capital | $804.0M | $4.24B | -$3.13B | -$513.0M | $797.0M | -$571.0M | $52.0M |
| Operating Cash Flow | $3.00B | $3.40B | $334.0M | $2.52B | $3.17B | $1.77B | $2.20B |
| Capital Expenditure | -$289.0M | -$229.0M | -$295.0M | -$375.0M | -$469.0M | -$434.0M | -$475.0M |
| Acquisitions | -$1.85B | $176.0M | $136.0M | -$10.0M | $21.0M | 0 | 0 |
| Stock Repurchased | 0 | 0 | 0 | 0 | 0 | -$235.0M | -$197.0M |
| Dividends Paid | 0 | 0 | 0 | 0 | -$14.55B | -$1.55B | -$1.58B |
| Free Cash Flow | $2.71B | $3.17B | $39.0M | $2.15B | $2.70B | $1.33B | $1.72B |
Cash Flow (Quarterly)
| Year | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|---|---|---|---|
| Operating Cash Flow | $294.0M | $854.0M | $489.0M | $688.0M |
| Capital Expenditure | -$98.0M | -$110.0M | -$139.0M | $138.8M |
| Free Cash Flow | $196.0M | $744.0M | $350.0M | $826.8M |
| Dividends Paid | -$398.0M | $1.18B | -$398.0M | -$398.0M |
| Stock-based Compensation | $25.0M | $30.0M | $29.0M | -$29.0M |
Growth & Margins (10y)
| Year | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Revenue Growth (YoY) | +1.0% | +4.1% | -0.7% | +3.3% | +0.1% | -2.1% | |
| Net Income Growth (YoY) | -161.3% | +336.4% | -0.7% | -19.4% | -38.1% | +42.7% | |
| EPS Growth (YoY) | -161.8% | +334.0% | -1.8% | -16.7% | -40.0% | +42.6% | |
| Shares Change (YoY) | -0.0% | +0.0% | +1.4% | +0.0% | +0.4% | +0.1% | |
| FCF Growth (YoY) | +16.9% | -98.8% | +5,412.8% | +25.5% | -50.5% | +29.0% | |
| Gross Margin | 53.5% | 54.2% | 55.9% | 55.4% | 56.0% | 58.0% | 58.1% |
| Operating Margin | 12.9% | -6.8% | 19.4% | 17.9% | 16.3% | 11.9% | 17.9% |
| EBITDA Margin | 21.7% | 25.8% | 24.3% | 21.9% | 20.6% | 16.0% | 19.4% |
| Net Margin | 10.0% | -6.1% | 13.8% | 13.8% | 10.8% | 6.7% | 9.7% |
| FCF Margin | 18.9% | 21.9% | 0.3% | 14.4% | 17.5% | 8.6% | 11.4% |
| Effective Tax Rate | 32.3% | 13.5% | 29.0% | 21.7% | 24.0% | 27.2% | 26.5% |
Per-Share Data (10y)
| Year | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| FCF Per Share | $1.43 | $1.68 | $0.02 | $1.12 | $1.41 | $0.69 | $0.90 |
| Dividends Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $7.60 | $0.81 | $0.82 |
| Shares Outstanding (Basic) | $1.89B | $1.89B | $1.89B | $1.91B | $1.85B | $1.92B | $1.92B |
What to look at in Consumer Defensive companies
- Gross margin (stable 5y) (Stable >=35%) — Brand pricing power — Coca-Cola does not drop margins.
- ROE / ROIC stable (ROE >=15% stable) — Defensive businesses have high consistent ROEs — Lynch's stalwarts.
- FCF / Net Income (>=90%) — Earnings to cash conversion — best names exceed 95%.
- Dividend growth 10y (>=6%/year) — Dividend Aristocrats raise 25+ years — moat signal.
- Payout Ratio (<75%) — >80% = dividend at risk. <60% comfortable.
- Net Debt / EBITDA (<2.5x) — Defensive with high debt loses its essence.
Profitability
| Return on Equity | 13.66% |
| Return on Invested Capital | 8.80% |
| Return on Assets | 5.43% |
| Gross Margin | 58.19% |
| Operating Margin | 19.52% |
| Net Margin | 10.76% |
Financial Health
| Debt / Equity | 0.80 |
| Current Ratio | 1.01 |
| Piotroski F-Score | 6 |
| Altman Z-Score | 2.08 |
Key Ratios (10y)
| Year | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| P/E | 35.39 | -57.23 | 24.45 | 24.91 | 23.92 | 39.22 | 22.32 |
| P/B | 0.00 | 2.77 | 2.49 | 2.58 | 3.55 | 4.20 | 3.06 |
| P/S | 3.55 | 3.51 | 3.38 | 3.45 | 2.58 | 2.62 | 2.18 |
| Gross Margin | 53.5% | 54.2% | 55.9% | 55.4% | 56.0% | 58.0% | 58.1% |
| Operating Margin | 12.9% | -6.8% | 19.4% | 17.9% | 16.3% | 11.9% | 17.9% |
| Net Margin | 10.0% | -6.1% | 13.8% | 13.8% | 10.8% | 6.7% | 9.7% |
Related companies: ADM · CHD · EL · HSY · JBS · K · KDP
Explore sector: Consumer Defensive · Household & Personal Products
More sections of KVUE: Overview · Valuation · Statistics · Estimates · Technical · Ownership · News · Events
Discover more: Weekly Radar: the S&P 500 through the Buffett and Lynch methods · Investment Academy — learn to analyze stocks